no mate that would be 8p. What they actually say, according to what I read is, if they can successfully progress their current and coming drugs along the preclinical stage including optimising the chemistry side. Which should take 2 years of hard work they think the company would be worth something like that.
This presumes: (a) they are successful with their drugs, chemistry and preclinical results; (b) They somehow get enough money to do part a; (c) no major hiccups/delays on the way and (d) The market place for these types of drugs is the same in 2 years time (not the market of cancer victims) the market of BIG BIO wanting to buy these types of drug development projects at extremely high prices!
In two years time with a, b, c, and d. SP = 8p ;-)
This is what I read in the results!
Eirx Therap stock quotes
Eirx Therap stock charts
Follow this thread
